SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2179121

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2179121

AI-Driven Clinical Trial Patient Matching Market Forecasts to 2034 - Global Analysis By Component (Software and Services), Solution Type, Technology, Deployment Mode, Application and By Geography

PUBLISHED:
PAGES: 300+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global AI-Driven Clinical Trial Patient Matching Market is accounted for $1.7 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 20.6% during the forecast period. The AI-Driven Clinical Trial Patient Matching Market encompasses intelligent solutions that analyze electronic health records, genomic information, and clinical trial eligibility criteria to identify suitable research participants. Increasing demand for faster patient recruitment, improved trial enrollment, and personalized clinical research is supporting market development. Integration of natural language processing, machine learning, and real-world data analytics enables automated eligibility screening and accurate patient-to-trial matching. Growing adoption of digital healthcare infrastructure creates opportunities for advanced clinical recruitment platforms.

Market Dynamics:

Driver:

Increasing demand for efficient patient recruitment and clinical trial enrollment

Increasing demand for efficient patient recruitment and clinical trial enrollment is driving market growth. Pharmaceutical companies and research organizations face challenges identifying eligible participants within complex clinical research protocols. AI-driven matching platforms analyze electronic health records, medical histories, and eligibility requirements to identify suitable candidates more efficiently. Growing emphasis on reducing recruitment delays and improving trial participation encourages technology adoption. Advancements in natural language processing, predictive analytics, and clinical data interoperability further strengthen demand for intelligent patient identification and enrollment solutions.

Restraint:

Limited clinical data interoperability and stringent patient privacy requirements

Limited clinical data interoperability and stringent patient privacy requirements restrain market growth. AI-driven patient matching systems require access to comprehensive electronic health records, genomic information, and clinical research databases. Fragmented healthcare information systems and inconsistent documentation standards complicate data integration and automated eligibility assessment. Compliance with patient consent, data protection, and clinical research regulations increases implementation complexity. High integration costs, limited access to representative training datasets, and concerns regarding algorithm transparency may further delay adoption across healthcare institutions.

Opportunity:

Expansion of precision medicine and AI-enabled genomic trial matching

Expansion of precision medicine and AI-enabled genomic trial matching presents significant growth opportunities. Pharmaceutical sponsors and healthcare providers are increasingly adopting biomarker-driven clinical trials that require precise identification of eligible participants. AI-powered platforms can combine genomic profiles, medical histories, and real-world clinical data to support personalized trial recommendations. Growing investment in oncology research and rare disease therapies encourages adoption. Advancements in multimodal artificial intelligence, knowledge graphs, and federated learning are expected to improve matching capabilities and expand clinical research participation.

Threat:

Algorithmic bias and cybersecurity risks affecting patient matching reliability

Algorithmic bias and cybersecurity risks affecting patient matching reliability pose significant challenges to market development. AI-driven platforms depend on sensitive healthcare information and complex predictive models, creating exposure to unauthorized access, data breaches, and inaccurate eligibility assessments. Incomplete or unrepresentative datasets may generate biased patient recommendations and reduce trial accessibility. Regulatory scrutiny surrounding automated clinical decision support can complicate implementation. Competition from conventional recruitment services and uncertainty regarding clinical workflow integration may further restrict adoption.

Covid-19 Impact:

The COVID-19 pandemic accelerated interest in AI-driven clinical trial patient matching technologies by highlighting the need for efficient participant identification and flexible research recruitment. Healthcare disruptions, travel restrictions, and reduced site access complicated conventional clinical trial enrollment. Pharmaceutical companies and research organizations increasingly explored digital recruitment, electronic health record screening, and remote eligibility assessment to maintain research continuity. Growing investment in virtual clinical research and data-driven recruitment technologies encouraged innovation. Post-pandemic adoption of decentralized trial models has supported continued demand for intelligent patient matching platforms.

The software segment is expected to be the largest during the forecast period

The software segment is expected to account for the largest market share during the forecast period due to increasing demand for automated eligibility screening, clinical data integration, and intelligent patient recruitment solutions. Pharmaceutical sponsors, hospitals, and research organizations require advanced software to analyze medical records, interpret trial criteria, and identify suitable participants. Growing adoption of electronic health records and cloud-based clinical research platforms supports software investment. Advancements in natural language processing, predictive analytics and interoperable healthcare data systems further strengthen segment growth.

The generative AI & large language models segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the generative AI & large language models segment is predicted to witness the highest growth rate due to increasing demand for automated interpretation of complex clinical trial eligibility criteria and unstructured medical records. Large language models can assist with extracting relevant patient characteristics, summarizing clinical information, and identifying potential trial matches. Growing investment in AI-enabled clinical research encourages innovation. Advancements in medical language models, retrieval-based validation, and human-supervised screening are expected to accelerate adoption across clinical recruitment platforms.

Region with largest share:

During the forecast period, North America is expected to hold the largest market share due to established clinical research infrastructure, substantial pharmaceutical investment, and widespread adoption of electronic health records. The United States leads regional development through advanced healthcare institutions, biotechnology companies, and clinical research organizations implementing AI-driven recruitment technologies. Growing investment in precision medicine, genomic testing, and real-world data analytics supports adoption. Collaboration among healthcare providers, pharmaceutical sponsors, and technology developers further strengthens regional demand for intelligent patient matching solutions.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding clinical research activities, increasing healthcare digitization, and growing investment in pharmaceutical development. China, India, Japan, and South Korea are advancing electronic health record infrastructure and technology-enabled clinical research programs. Increasing demand for efficient recruitment across diverse patient populations encourages platform deployment. Government-supported healthcare modernization and partnerships among hospitals, research organizations, and technology providers are expected to accelerate regional adoption of AI-driven patient matching solutions.

Key players in the market

Some of the key players in the AI-Driven Clinical Trial Patient Matching Market include Tempus AI, Inc., TriNetX, LLC, IQVIA Holdings Inc., Medidata Solutions, Inc., ConcertAI, LLC, Mendel, Massive Bio, Inc., Antidote Technologies, Inc., Trialbee AB, Triomics, Inc., Paradigm Health, Inc., Reify Health, Inc., Clinerion AG, HealthMatch, Komodo Health, Inc., myTomorrows, TrialX, Inc., and HEALWELL AI Inc.

Key Developments:

In October 2026, Tempus AI, Inc. expanded its strategic collaboration with Bristol Myers Squibb through a multi-year agreement to provide multimodal oncology datasets and access to its AI-powered Lens Platform. The collaboration supports advanced clinical data analysis, biomarker research, and oncology drug development, strengthening the data infrastructure relevant to precision patient identification.

In April 2026, Massive Bio, Inc. announced a collaboration with OpenAI to advance automated clinical trial eligibility interpretation and patient pre-screening. The initiative converts complex clinical trial protocols into machine-readable criteria, enabling faster identification of potentially eligible oncology and hematology patients.

In April 2026, Massive Bio, Inc. also published a prospective study evaluating its neuro-symbolic, multi-agent AI platform across 3,804 cancer patients. The study reported more than 17,000 oncologist-confirmed trial matches and approximately fourfold faster matching compared with conventional screening methods.

Components Covered:

  • Software
  • Services

Solution Types Covered:

  • EHR-Based Patient Matching Platforms
  • Genomic & Biomarker-Based Matching Platforms
  • Patient-Facing Clinical Trial Matching Platforms
  • Automated Eligibility Screening Solutions
  • Oncology-Specific Trial Matching Solutions
  • Real-World Data-Based Matching Platforms
  • Multimodal Patient Matching Platforms
  • Other Solution Types

Technologies Covered:

  • Machine Learning & Predictive Analytics
  • Deep Learning & Neural Networks
  • Natural Language Processing (NLP)
  • Generative AI & Large Language Models
  • Knowledge Graphs & Semantic Matching
  • Clinical Data Mining & Real-World Data Analytics
  • Multimodal AI & Federated Learning
  • Other Technologies

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises
  • Hybrid Deployment

Applications Covered:

  • Patient Identification & Recruitment
  • Clinical Trial Eligibility Screening
  • Patient-to-Trial Matching
  • Oncology Clinical Trial Matching
  • Rare Disease Clinical Trial Matching
  • Trial Feasibility & Site Selection
  • Patient Enrollment Optimization
  • Other Applications

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC41196

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Driven Clinical Trial Patient Matching Market, By Component

  • 5.1 Software
    • 5.1.1 Patient Matching & Eligibility Screening Software
    • 5.1.2 Clinical Data Integration & Analytics Software
    • 5.1.3 Patient Recruitment & Engagement Software
  • 5.2 Services
    • 5.2.1 Implementation & Integration Services
    • 5.2.2 Data Management & Consulting Services
    • 5.2.3 Technical Support & Maintenance Services

6 Global AI-Driven Clinical Trial Patient Matching Market, By Solution Type

  • 6.1 EHR-Based Patient Matching Platforms
  • 6.2 Genomic & Biomarker-Based Matching Platforms
  • 6.3 Patient-Facing Clinical Trial Matching Platforms
  • 6.4 Automated Eligibility Screening Solutions
  • 6.5 Oncology-Specific Trial Matching Solutions
  • 6.6 Real-World Data-Based Matching Platforms
  • 6.7 Multimodal Patient Matching Platforms
  • 6.8 Other Solution Types

7 Global AI-Driven Clinical Trial Patient Matching Market, By Technology

  • 7.1 Machine Learning & Predictive Analytics
  • 7.2 Deep Learning & Neural Networks
  • 7.3 Natural Language Processing (NLP)
  • 7.4 Generative AI & Large Language Models
  • 7.5 Knowledge Graphs & Semantic Matching
  • 7.6 Clinical Data Mining & Real-World Data Analytics
  • 7.7 Multimodal AI & Federated Learning
  • 7.8 Other Technologies

8 Global AI-Driven Clinical Trial Patient Matching Market, By Deployment Mode

  • 8.1 Cloud-Based
  • 8.2 On-Premises
  • 8.3 Hybrid Deployment

9 Global AI-Driven Clinical Trial Patient Matching Market, By Application

  • 9.1 Patient Identification & Recruitment
  • 9.2 Clinical Trial Eligibility Screening
  • 9.3 Patient-to-Trial Matching
  • 9.4 Oncology Clinical Trial Matching
  • 9.5 Rare Disease Clinical Trial Matching
  • 9.6 Trial Feasibility & Site Selection
  • 9.7 Patient Enrollment Optimization
  • 9.8 Other Applications

10 Global AI-Driven Clinical Trial Patient Matching Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Tempus AI, Inc.
  • 13.2 TriNetX, LLC
  • 13.3 IQVIA Holdings Inc.
  • 13.4 Medidata Solutions, Inc.
  • 13.5 ConcertAI, LLC
  • 13.6 Mendel
  • 13.7 Massive Bio, Inc.
  • 13.8 Antidote Technologies, Inc.
  • 13.9 Trialbee AB
  • 13.10 Triomics, Inc.
  • 13.11 Paradigm Health, Inc.
  • 13.12 Reify Health, Inc.
  • 13.13 Clinerion AG
  • 13.14 HealthMatch
  • 13.15 Komodo Health, Inc.
  • 13.16 myTomorrows
  • 13.17 TrialX, Inc.
  • 13.18 HEALWELL AI Inc.
Product Code: SMRC41196

List of Tables

  • Table 1 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Software (2023-2034) ($MN)
  • Table 4 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient Matching & Eligibility Screening Software (2023-2034) ($MN)
  • Table 5 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Clinical Data Integration & Analytics Software (2023-2034) ($MN)
  • Table 6 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient Recruitment & Engagement Software (2023-2034) ($MN)
  • Table 7 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Services (2023-2034) ($MN)
  • Table 8 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Implementation & Integration Services (2023-2034) ($MN)
  • Table 9 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Data Management & Consulting Services (2023-2034) ($MN)
  • Table 10 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Technical Support & Maintenance Services (2023-2034) ($MN)
  • Table 11 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Solution Type (2023-2034) ($MN)
  • Table 12 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By EHR-Based Patient Matching Platforms (2023-2034) ($MN)
  • Table 13 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Genomic & Biomarker-Based Matching Platforms (2023-2034) ($MN)
  • Table 14 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient-Facing Clinical Trial Matching Platforms (2023-2034) ($MN)
  • Table 15 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Automated Eligibility Screening Solutions (2023-2034) ($MN)
  • Table 16 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Oncology-Specific Trial Matching Solutions (2023-2034) ($MN)
  • Table 17 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Real-World Data-Based Matching Platforms (2023-2034) ($MN)
  • Table 18 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Multimodal Patient Matching Platforms (2023-2034) ($MN)
  • Table 19 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Other Solution Types (2023-2034) ($MN)
  • Table 20 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Technology (2023-2034) ($MN)
  • Table 21 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Machine Learning & Predictive Analytics (2023-2034) ($MN)
  • Table 22 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Deep Learning & Neural Networks (2023-2034) ($MN)
  • Table 23 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Natural Language Processing (NLP) (2023-2034) ($MN)
  • Table 24 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Generative AI & Large Language Models (2023-2034) ($MN)
  • Table 25 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Knowledge Graphs & Semantic Matching (2023-2034) ($MN)
  • Table 26 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Clinical Data Mining & Real-World Data Analytics (2023-2034) ($MN)
  • Table 27 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Multimodal AI & Federated Learning (2023-2034) ($MN)
  • Table 28 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 29 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 30 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 31 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By On-Premises (2023-2034) ($MN)
  • Table 32 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 33 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Application (2023-2034) ($MN)
  • Table 34 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient Identification & Recruitment (2023-2034) ($MN)
  • Table 35 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Clinical Trial Eligibility Screening (2023-2034) ($MN)
  • Table 36 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient-to-Trial Matching (2023-2034) ($MN)
  • Table 37 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Oncology Clinical Trial Matching (2023-2034) ($MN)
  • Table 38 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Rare Disease Clinical Trial Matching (2023-2034) ($MN)
  • Table 39 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Trial Feasibility & Site Selection (2023-2034) ($MN)
  • Table 40 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Patient Enrollment Optimization (2023-2034) ($MN)
  • Table 41 Global AI-Driven Clinical Trial Patient Matching Market Outlook, By Other Applications (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!